DRC and WHO Move Forward on Plans for Phase 3 Ebola Vaccine Trial
The Democratic Republic of the Congo and the World Health Organization are negotiating to accelerate the launch of a multi-armed Phase 3 clinical trial for Ebola vaccines. The trial aims to evaluate multiple vaccine candidates. The talks signify progress in the fight against Ebola outbreaks.
Related stories
WHO issues emergency guidance on Ebola vaccine for Bundibugyo virus outbreak in DRC · Infectious disease
AbbVie's etentamig succeeds in Phase 3 myeloma trial, cutting progression risk by 60% · Drug development
DRC Ebola Outbreak Surpasses 5,000 Cases; US Global Health Leadership Under Scrutiny · Infectious disease
GSK advances mRNA flu shot to late-stage trial after positive Phase 2 data · Infectious disease
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says.” Browse more stories.